佐力药业(300181) - 2021 Q3 - 季度财报

Financial Performance - Revenue for Q3 2021 reached ¥380,795,239.07, an increase of 25.77% compared to the same period last year[4] - Net profit attributable to shareholders was ¥44,956,675.45, up 41.98% year-on-year[4] - Net profit excluding non-recurring items was ¥44,439,424.73, reflecting a 46.08% increase compared to the previous year[4] - Basic earnings per share for Q3 2021 was ¥0.0739, up 42.05% year-on-year[4] - The net profit for the current period reached ¥141,046,881.84, a significant increase from ¥66,027,122.38 in the previous period, representing a growth of approximately 113%[33] - The basic earnings per share rose to ¥0.2161 from ¥0.1025, showing an increase of approximately 111%[37] - The total comprehensive income for the current period was ¥750,851,834.92, compared to ¥66,027,122.38 in the previous period, indicating a substantial increase[37] Assets and Liabilities - Total assets at the end of Q3 2021 amounted to ¥3,319,227,797.46, a growth of 34.39% from the end of the previous year[4] - Non-current assets totaled ¥2,384,917,487.33, a substantial increase from ¥1,504,500,505.10, representing a growth of approximately 58.2%[26] - The total assets of the company reached ¥3,319,227,797.46, up from ¥2,469,876,379.74, indicating a growth of around 34.4%[29] - The company's total liabilities increased to ¥899,009,215.57 from ¥750,429,212.25, reflecting a rise of about 19.7%[29] - The company reported a decrease in short-term borrowings to ¥184,205,534.72 from ¥302,849,294.47, a reduction of about 39.2%[26] Cash Flow - Cash flow from operating activities for the year-to-date was ¥185,971,918.34, an increase of 27.21%[4] - The net cash inflow from operating activities was 185.97 million RMB, up 39.78 million RMB, or 27.21% year-over-year, primarily due to increased cash flow from sales[14] - Cash flow from operating activities generated a net amount of ¥185,971,918.34, compared to ¥146,188,796.32 in the previous period, representing an increase of about 27%[41] - The company achieved a net cash inflow from investment activities of ¥34,688,285.91, a recovery from a net outflow of ¥76,155,771.65 in the previous period[41] Expenses - Research and development expenses increased by 1,167.37 million RMB, or 57.82% year-over-year, totaling 31.86 million RMB, reflecting the company's commitment to enhancing R&D investment[11] - The company reported a significant increase in sales expenses, totaling 527.26 million RMB, up 13.90 million RMB, or 35.80% year-over-year, in line with revenue growth[11] - The company's financial expenses decreased by 497.47 million RMB, or 40.86% year-over-year, totaling 7.20 million RMB, due to reduced bank loan interest expenses[11] - The income tax expense increased by 1,535.31 million RMB, or 217.14% year-over-year, totaling 22.42 million RMB, reflecting higher profit levels[11] Shareholder Information - Shareholders' equity reached ¥2,247,535,221.02, representing a 40.22% increase year-on-year[4] - The company’s major shareholder, Yu Youqiang, has pledged 90 million shares, representing 69.28% of his holdings and 14.79% of the total share capital[20] Market and Strategic Initiatives - The company is actively pursuing market expansion and product development strategies to enhance its competitive position in the industry[11] - The company optimized its capital structure, reducing short-term borrowings by 39.18%[10] Other Financial Metrics - The company reported investment income of ¥801,339.44, a recovery from a loss of ¥210,990.85 in the previous period[33] - The total revenue from sales of goods and services amounted to ¥1,111,249,189.08, compared to ¥796,205,175.50 in the previous period, indicating a growth of approximately 39%[38] - The operating profit for the current period was ¥164,200,430.01, up from ¥73,501,346.47, reflecting an increase of around 123%[33] - The company reported a cash outflow of $463.40 million from financing activities, which is significantly higher than the previous period's outflow of $317.90 million[44] Audit and Compliance - The company has not yet audited its third-quarter report, which may affect the reliability of the financial data presented[54] - The company executed a new leasing standard starting from 2021, which resulted in adjustments to its financial statements[45]